PrimaNova Technologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PrimaNova Technologies - overview
Established
2020
Location
Shenzhen, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Based in Shenzhen, China, and founded in 2020, PrimaNova Technologies operates as a neurological disease solution provider, specializing in medical devices for neurosurgery. The company has established R&D centers in the US and Europe. It has cooperated with Healthcare Capital Partners and TheraNova Medical Device Innovation. Its wireless intracranial multiparameter monitoring system completes clinical trials.
In April 2024, PrimaNova Technologies closed a series A funding. PrimaNova Technologies has built product pipelines that focus on neuromonitoring systems, cerebrospinal fluid management systems, intraoperative devices, and surgical robots. Its main product is the wireless intracranial multiparameter monitoring system Sencere, which is capable of real-time continuous monitoring of ICP, ICT, IBP, CPP and other parameters. The company generates revenue by offering neuromonitoring systems, cerebrospinal fluid management systems, intraoperative instruments, and surgical robots.
Current Investors
Shanghai Healthcare Capital, Langyao Capital, JIF Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Surgical Devices, Medical Software
Website
www.primanovamed.com
Verticals
Manufacturing, Robotics
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.